1MARTIN G S,MANNINO D M,EATON S,et al. The ep -idemiology of sepsis in the United States form 1979 through2000 [J]. N Engl J Med,2003,348:1 546- 1 554.
2Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med,2003, 348 : 1546-1554.
3Marr KA, Seidel K, Slavin MA, et al. Prolonged flueonazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood, 2000,96,2055-2061.
4Cordonnier C, Ribaud P, Herbrecht R, et al. Prognostic factors for death due to invasive aspergillosis after hematopoietie stem cell transplantation : a 1 -year retrospective study of consecutive patients at French transplantation centres. Clin Infect Dis ,2006,42:955-963.
5Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis,2002,21:161-172.
6Kedziderska A, Kochan P, Pietrzyk A, et al. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galaetomannan, mannan and 1-3-beta-D glucan antigens. Eur J Clin Mierobiol Infect Dis,2007,26:755-766.
7Sarfati J, Boueias DG, Large JP. Antigens of Aspergillus fumigatus produced in vivo. J Med Vet Myeol, 1995,33:9-14.
8Stynen D, Sarfati J, Goris A, et al. Rat monoelonal antibodies againstAspergillus galactomannan. Infect Immun, 1992,60:2237-2245.
9Kauffmann-Lacroix C, Rodier MH, Jacquemin JL, et al. Detection of galactomannan for diagnosis of fungal rhinosinusitis. J Clin Mierobiol, 2001,39:4593 -4594.
10Verweij PE, Stynen D, Rijs AJ, et al. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol, 1995,33:1912-1914.
